Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Gilead sciences, inc. crawled time : 10:00 save search
New Data Presented at EACS 2023 Further Demonstrate Strong Clinical Profile of Twice-Yearly Sunlenca® for Adults With Multi-Drug Resistant HIV
Published: 2023-10-20 (Crawled : 10:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.38%
H: 0.44%
C: -1.19%
sunlenca hiv
Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities
Published: 2023-10-19 (Crawled : 10:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.75%
H: 1.01%
C: -0.8%
biktarvy treatment hiv
Hepcludex® (Bulevirtide) Demonstrates Sustained Efficacy and Safety Profile in People With Chronic Hepatitis Delta Virus at 96 Weeks
Published: 2023-06-23 (Crawled : 10:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.28%
H: 0.04%
C: -1.1%
hepcludex hepatitis virus
Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published: 2023-05-15 (Crawled : 10:00) - prnewswire.com
UCBJY | $65.26 -4.38% 5.9K
|
Manufacturing
|
| O: 1.79%
H: 0.18%
C: -0.06%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.61%
H: 0.3%
C: 0.24%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.01%
H: 0.14%
C: -0.78%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.22%
H: 0.14%
C: -0.2%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.35%
H: 0.83%
C: -0.73%
VRTX | $400.66 -1.05% -1.06% 810K
|
Health Technology
|
| O: 0.17%
H: 1.07%
C: 0.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.13%
H: 0.42%
C: 0.4%
research global growth market
Gilead Announces First Global Regulatory Approval of Sunlenca® (Lenacapavir), the Only Twice-Yearly HIV Treatment Option
Published: 2022-08-22 (Crawled : 10:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.2%
H: 0.06%
C: -1.3%
sunlenca treatment global hiv approval
Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19
Published: 2021-12-07 (Crawled : 10:00) - globenewswire.com
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
europe covid covid-19
Biotechnology Market Size Worth $2.44 Trillion By 2028 | CAGR 15.83%
Published: 2021-04-13 (Crawled : 10:00) - prnewswire.com
WAT | $310.25 -0.97% 0.0% 530K
|
Health Technology
|
| O: 0.05%
H: 0.35%
C: 0.23%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.55%
H: 1.9%
C: 1.31%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 1.19%
H: 0.64%
C: -0.67%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 1.53%
H: 0.54%
C: 0.35%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.32%
H: 0.85%
C: 0.49%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -2.96%
H: 1.96%
C: 1.67%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.66%
H: 0.86%
C: 0.48%
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: 0.29%
H: 1.72%
C: 0.75%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.32%
H: 1.19%
C: 0.68%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.08%
H: 0.48%
C: 0.32%
biotech technology iot
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.